Orwin John A
Travere Therapeutics, Inc. ยท Director
Orwin John A is listed in public filings as director. This Orwin John A insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Travere Therapeutics, Inc. (TVTX), AnaptysBio, Inc. (ANAB), and CARGO Therapeutics, Inc. Common Stock (CRGX). Investors use Orwin John A's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.
Latest Actions
| Company | Holding Value | Last Transaction | Amount | Transaction Price | Current Price |
|---|---|---|---|---|---|
| $507k12k shares | Grant / ExerciseMay 19, 2026 | $507.1K12k shares | $42.26 | -- | |
| --39.4k shares | Grant / ExerciseMay 19, 2026 | Disclosure amount unavailable4k shares | -- | -- |
Insider Trades History
| Company | Holding Value | Last Transaction | Amount | Transaction Price | Current Price |
|---|---|---|---|---|---|
| $362k8.3k shares | OtherApr 20, 2026 | $362.3K8.3k shares | $43.91 | -- | |
| $350k16.5k shares | OtherApr 20, 2026 | $349.8K16.5k shares | $21.19 | -- | |
| $265k8.3k shares | Grant / ExerciseApr 20, 2026 | $265.4K8.3k shares | $32.17 | -- | |
| $256k16.5k shares | Grant / ExerciseApr 20, 2026 | $256.4K16.5k shares | $15.53 | -- | |
| $245k16.5k shares | OtherApr 20, 2026 | $244.8K16.5k shares | $14.83 | -- | |
| $207k10.6k shares | OtherApr 20, 2026 | $206.7K10.6k shares | $19.50 | -- | |
| $179k16.5k shares | Grant / ExerciseApr 20, 2026 | $179.5K16.5k shares | $10.87 | -- | |
| $151k10.6k shares | Grant / ExerciseApr 20, 2026 | $151.5K10.6k shares | $14.29 | -- | |
| $65k3.3k shares | OtherApr 20, 2026 | $64.6K3.3k shares | $19.50 | -- | |
| $47k3.3k shares | Grant / ExerciseApr 20, 2026 | $47.3K3.3k shares | $14.29 | -- | |
| $362k8.3k shares | Grant / ExerciseJan 6, 2026 | $362.3K8.3k shares | $43.91 | -- | |
| --6k shares | Grant / ExerciseJan 6, 2026 | Disclosure amount unavailable6k shares | -- | -- | |
| --1.3k shares | Grant / ExerciseSep 15, 2025 | Disclosure amount unavailable1.3k shares | -- | -- | |
| $025k shares | OtherAug 19, 2025 | $108.8K25k shares | $4.35 | -- | |
| $015.9k shares | OtherAug 19, 2025 | $17.3K15.9k shares | $1.09 | -- | |
| $109k25k shares | Grant / ExerciseJun 18, 2025 | $108.8K25k shares | $4.35 | -- | |
| --6k shares | Grant / ExerciseJun 15, 2025 | Disclosure amount unavailable6k shares | -- | -- | |
| $412k19.5k shares | Grant / ExerciseMay 15, 2025 | $412.4K19.5k shares | $21.15 | -- | |
| --35.4k shares | Grant / ExerciseMay 15, 2025 | Disclosure amount unavailable6.5k shares | -- | -- | |
| $245k16.5k shares | Grant / ExerciseJan 7, 2025 | $244.8K16.5k shares | $14.83 | -- | |
| --6k shares | Grant / ExerciseJan 7, 2025 | Disclosure amount unavailable6k shares | -- | -- | |
| --2.6k shares | Grant / ExerciseSep 15, 2024 | Disclosure amount unavailable1.3k shares | -- | -- |